vialaudit
The Roundup
fox04-dri · kentucky

Is FOX04-DRI legal in Kentucky?

status · caveats apply
Preclinical 43-aa senolytic peptide; no human clinical trials registered; no FDA approval; pre-IND. No state-level peptide restrictions beyond federal law in Kentucky.

category: no approval · last verified May 13, 2026

§ 01

Quick answer

Preclinical 43-aa senolytic peptide; no human clinical trials registered; no FDA approval; pre-IND. No state-level peptide restrictions beyond federal law in Kentucky.
§ 02

Full status breakdown

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
No PCAC vote.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Pre-IND. FDCA §505 applies if marketed for human use.
Personal possession: Not federally criminalized.

Kentucky — state-specific

Sport-body status

WADA 2026
not on prohibited list
Not explicitly named.
USADA
unknown
NCAA
unknown

What we couldn’t verify

§ 03

Also known as

FOX04-DRI is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • FOXO4-DRI
  • FOXO4-D-Retro-Inverso
  • senolytic peptide
  • Baar et al. 2017 peptide
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch